โš  LIVE โ€” European Consumer Safety Watch ๐Ÿ’Š Etichetta canale medico: 18 negli ultimi 7 giorni ๐ŸŽ Canale alimentare: 180 negli ultimi 7 giorni ๐Ÿงธ Canale: prodotti: 48 negli ultimi 7 giorni ๐ŸŸข Monitoraggio: EMA ยท RASFF ยท NVWA ยท FAGG ยท FAVV ยท EFSA ยท Safety Gate โฑ Ultimo recupero: 3 ore fa โš  LIVE โ€” European Consumer Safety Watch ๐Ÿ’Š Etichetta canale medico: 18 negli ultimi 7 giorni ๐ŸŽ Canale alimentare: 180 negli ultimi 7 giorni ๐Ÿงธ Canale: prodotti: 48 negli ultimi 7 giorni ๐ŸŸข Monitoraggio: EMA ยท RASFF ยท NVWA ยท FAGG ยท FAVV ยท EFSA ยท Safety Gate โฑ Ultimo recupero: 3 ore fa
๐Ÿ›ก๏ธ EUSW
๐Ÿ‡ฎ๐Ÿ‡น
๐Ÿ’Š

Spikevax (previously COVID-19 Vaccine Moderna)

COVID-19 mRNA vaccine
Infezione da virus COVID-19
โœ… Autorizzato
โœ…
Nessun allarme attivo
Questo medicinale non presenta carenze in corso, lettere di sicurezza o richiami.

A cosa serve

Spikevax is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older. The use of this vaccine should be in accordance with official recommendations. Spikevax bivalent Original/Omicron BA.1 is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against COVID-19. The use of this vaccine should be in accordance with official recommendations. Spikevax bivalent Original/Omicron BA.4-5 is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older. The use of this vaccine should be in accordance with official recommendations. Spikevax XBB.1.5 is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older. Spikevax JN.1 is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older. The use of this vaccine should be in accordance with official recommendations. Spikevax JN.1 is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older. The use of this vaccine should be in accordance with official recommendations. Spikevax LP.8.1 is indicated for active immunisation to prevent COVID 19 caused by SARS-CoV-2 in individuals 6 months of age and older. The use of this vaccine should be in accordance with official recommendations.

โš ๏ธ Sicurezza del paziente

No

โš ๏ธ Aggregiamo avvisi ufficiali. Non forniamo consulenze mediche. Per decisioni mediche o legali, consulta l'ente di riferimento e un professionista qualificato.